Long-term results of continuous subcutaneous recombinant PTH (1-34) infusion in children with refractory hypoparathyroidism

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 11, 2011, Pages 3308-3312

  Linglart, Agnès ^a   Rothenbuhler, Anya ^a   Gueorgieva, Iva ^a   Lucchini, Philippe ^a   Silve, Caroline ^a,b   Bougnères, Pierre ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALFACALCIDOL; CALCIUM; PARATHYROID HORMONE[1-34]; RECOMBINANT PARATHYROID HORMONE; VITAMIN D;

AIRE GENE; CASE REPORT; CHILD; CONFERENCE PAPER; CONTINUOUS INFUSION; DRUG DOSE REDUCTION; GENE; GENE MUTATION; HOME CARE; HOMOZYGOTE; HUMAN; HYPERCALCEMIA; HYPERCALCIURIA; HYPOCALCEMIA; HYPOPARATHYROIDISM; INFUSION PUMP; MALABSORPTION; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; REFRACTORY HYPOPARATHYROIDISM; SEIZURE; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; CHILD; HUMANS; HYPOPARATHYROIDISM; INFUSIONS, SUBCUTANEOUS; MALE; PARATHYROID HORMONE; POLYENDOCRINOPATHIES, AUTOIMMUNE; RECOMBINANT PROTEINS; TRANSCRIPTION FACTORS; TREATMENT OUTCOME;

EID: 80655148327     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-1359     Document Type: Conference Paper

References (10)

1. Thakker RV 2004 Genetics of endocrine and metabolic disorders: parathyroid. Rev Endocr Metab Disord 5:37-51 (Pubitemid 38374697)
2. Winer KK, Yanovski JA, Cutler Jr GB 1996 Synthetic human parathyroid hormone 1-34 vs calcitriol and calcium in the treatment of hypoparathyroidism. JAMA 276:631-636 (Pubitemid 26278069)
3. Winer KK, Yanovski JA, Sarani B, Cutler Jr GB 1998 A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1-34 in treatment of hypoparathyroidism. J Clin Endocrinol Metab 83:3480-3486 (Pubitemid 28500875)
4. Winer KK, Ko CW, Reynolds JC, Dowdy K, Keil M, Peterson D, Gerber LH, McGarvey C, Cutler Jr GB 2003 Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium. J Clin Endocrinol Metab 88:4214-4220 (Pubitemid 37153722)
5. Winer KK, Sinaii N, Reynolds J, Peterson D, Dowdy K, Cutler Jr GB 2010 Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1-34 versus calcitriol and calcium. J Clin Endocrinol Metab 95:2680-2688
6. Winer KK, Sinaii N, Peterson D, Sainz Jr B, Cutler Jr GB 2008 Effects of once versus twice-daily parathyroid hormone 1-34 therapy in children with hypoparathyroidism. J Clin Endocrinol Metab 93:3389-3395
7. Satterwhite J, Heathman M, Miller PD, Marín F, Glass EV, Dobnig H 2010 Pharmacokinetics of teriparatide (rhPTH[1-34]) and calcium pharmacodynamics in postmenopausal women with osteoporosis. Calcif Tissue Int 87:485-492
8. Eugster EA, Francis G 2006 Position statement: continuous subcutaneous insulin infusion in very young children with type 1 diabetes. Pediatrics 118:e1244-e1249 (Pubitemid 46393819)
9. Bougnères PF, Landier F, Lemmel C, Mensire A, Chaussain JL 1984 Insulin pump therapy in young children with type 1 diabetes. J Pediatr 105:212-217 (Pubitemid 14060208)
10. Vahle JL, Sato M, Long GG, Young JK, Francis PC, Engelhardt JA, Westmore MS, Linda Y, Nold JB 2002 Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety. Toxicol Pathol 30:312-321 (Pubitemid 34556102)